@article{f1b36ac7d51b4e8787fb5addf6b6bff8,
title = "Informing Healthcare Decisions with Observational Research Assessing Causal Effect",
abstract = "Rationale: Decisions in medicine are made on the basis of knowledge and reasoning, often in shared conversations with patients and families in consideration of clinical practice guideline recommendations, individual preferences, and individual goals. Observational studies can provide valuable knowledge to inform guidelines, decisions, and policy. Objectives: The American Thoracic Society (ATS) created a multidisciplinary ad hoc committee to develop a research statement to clarify the role of observational studies—alongside randomized controlled trials (RCTs)—in informing clinical decisions in pulmonary, critical care, and sleep medicine. Methods: The committee examined the strengths of observational studies assessing causal effects, how they complement RCTs, factors that impact observational study quality, perceptions of observational research, and, finally, the practicalities of incorporating observational research into ATS clinical practice guidelines. Measurements and Main Results: There are strengths and weakness of observational studies as well as RCTs. Observational studies can provide evidence in representative and diverse patient populations. Quality observational studies should be sought in the development of ATS clinical practice guidelines, and medical decision-making in general, when 1) no RCTs are identified or RCTs are appraised as being of low- or very low-quality (replacement); 2) RCTs are of moderate quality because of indirectness, imprecision, or inconsistency, and observational studies mitigate the reason that RCT evidence was downgraded (complementary); or 3) RCTs do not provide evidence for outcomes that a guideline committee considers essential for decision-making (e.g., rare or long-term outcomes; “sequential”). Conclusions: Observational studies should be considered in developing clinical practice guidelines and in making clinical decisions.",
keywords = "Evidence synthesis, Observational studies, Practice guidelines",
author = "Gershon, {Andrea S.} and Lindenauer, {Peter K.} and Wilson, {Kevin C.} and Louise Rose and Walkey, {Allan J.} and Mohsen Sadatsafavi and Anstrom, {Kevin J.} and Au, {David H.} and Bender, {Bruce G.} and Brookhart, {M. Alan} and Dweik, {Raed A.} and Han, {Mei Lan K.} and Joo, {Min J.} and Valery Lavergne and Mehta, {Anuj B.} and Marc Miravitlles and Mularski, {Richard A.} and Nicolas Roche and Eyal Oren and Riekert, {Kristin A.} and Schoenberg, {Noah C.} and Stukel, {Therese A.} and Weiss, {Curtis H.} and Hannah Wunsch and Africk, {Joel J.}",
note = "Funding Information: 4Respiratory Health Association, Chicago, Illinois; 5Department of Biostatistics and Bioinformatics and 8Department of Population Health Sciences, Duke University, Durham, North Carolina; 6Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington; 7Division of Pediatric Behavioral Health, Center for Health Promotion, and 12Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colorado; 9Respiratory Institute, Cleveland Clinic, Cleveland, Ohio; 10Division of Pulmonary & Critical Care, University of Michigan, Ann Arbor, Michigan; 11Department of Microbiology, Infectious Medicine, and Immunology, University of Montreal, Montreal, Quebec, Canada; 13Department of Pneumology, Vall d{\textquoteright}Hebron University Hospital, Barcelona, Spain; 14Department of Pulmonary and Critical Care Medicine, Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon; 15Division of Epidemiology & Biostatistics, School of Public Health, San Diego State University, San Diego, California; 16Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, John Hopkins University, Baltimore, Maryland; 17Department of Respiratory Medicine, Cochin Hospital and Institute, APHP Center University, Paris, France; 18Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King{\textquoteright}s College London, London, United Kingdom; 19Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada; 20Department of Internal Medicine, Pulmonary and Critical Care Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts; 21ICES, Toronto, Ontario, Canada; 22Institute of Health Policy, Management and Evaluation, 25Department of Anesthesia, and 26Interdepartmental Division of Critical Care, University of Toronto, Toronto, Ontario, Canada; 23Division of Pulmonary, Allergy, Sleep, and Critical Care Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts; and 24NorthShore University Health System, Evanston, Illinois Author Disclosures: J.A.K. served on a data safety and monitoring board for Sanofi; and received research support from Inogen, PCORI, National Institutes of Health, and ResMed. K.J.A. served on an advisory committee for Promedior; served as a consultant for AstraZeneca, Janssen, and Promedior; served on a data safety and monitoring board for Boehringer Ingelheim and Promedior; and received research support from Boehringer Ingelheim and Bristol Myers Squibb. D.H.A. served as a consultant for Gilead; served on a data safety and monitoring board for Novartis; and received research support from the American Lung Association. M.A.B. served on an advisory committee for AbbVie, Amgen, Atara Biotherapeutics, Brigham and Women{\textquoteright}s Hospital, Merck, and Vertex; and has equity interest in NoviSci. M.K.H. served as a consultant for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, and Mylan; served on a data and safety monitoring board and as a speaker for Novartis; and received research support from Novartis and Sunovion. V.L. received research support from Fonds de Recherche du Qu{\'e}bec–Sant{\'e} and is employed as the Senior Methodologist and Editor for the department of Clinical Affairs and Practice Guideline. M.M. served as a consultant for AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, CSL Behring, Ferrer, Gebro, GlaxoSmithKline, Grifols, Kamada, Laboratorios Esteve, Mereo, Novartis, pH Pharma, Sanofi, Spin Therapeutics, Teva, and Verona; served as a speaker for AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, Cipla, CSL Behring, Grifols, Menarini, Novartis, Rovi, Sandoz, and Zambon; and received research support from GlaxoSmithKline and Grifols. R.A.M. received research support from GlaxoSmithKline. K.A.R. served on an advisory committee for Gilead; and received royalties from Springer Publishing. N.R. served on an advisory committee for AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis, Sanofi, and Teva; served as a speaker for AstraZeneca, Chiesi, Novartis, Teva, and Zambon; received research support from Boehringer Ingelheim, Novartis, Pfizer, and Zambon; and received personal fees from GlaxoSmithKline and Pfizer. M.S. served on an advisory committee for AstraZeneca and GlaxoSmithKline; served as a speaker for Boehringer Ingelheim and Teva; and received research support from AstraZeneca and Boehringer Ingelheim. A.J.W. received royalties from UpToDate. C.H.W. served on an advisory committee and as a speaker for Mylan/Theravance; and received research support from the National Institutes of Health. K.C.W. is employed by the American Thoracic Society as Chief of Documents and Documents Editor with interest in the success of ATS guidelines. A.S.G., P.K.L., J.J.A., B.G.B., R.A.D., M.J.J., A.B.M., E.O., L.R., N.C.S., T.A.S., and H.W. reported no commercial or relevant noncommercial interests. Funding Information: Supported by the American Thoracic Society. Publisher Copyright: Copyright {\textcopyright} 2021 by the American Thoracic Society",
year = "2021",
month = jan,
day = "1",
doi = "10.1164/rccm.202010-3943ST",
language = "English (US)",
volume = "203",
pages = "14--23",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "1",
}